DCM

DAFNA Capital Management Portfolio holdings

AUM $362M
This Quarter Return
+1.54%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$266M
AUM Growth
+$266M
Cap. Flow
+$27.1M
Cap. Flow %
10.17%
Top 10 Hldgs %
46.64%
Holding
94
New
15
Increased
27
Reduced
15
Closed
6

Top Buys

1
ELOX
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$3.74M
2
QNCX icon
Quince Therapeutics
QNCX
$2.78M
3
TBIO
Translate Bio, Inc. Common Stock
TBIO
$2.25M
4
EPZM
Epizyme, Inc
EPZM
$2.18M
5
ARAY icon
Accuray
ARAY
$2.03M

Top Sells

1
GNCA
Genocea Biosciences, Inc.
GNCA
$4.92M
2
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$1.59M
3
ADXS
Advaxis, Inc.
ADXS
$1.2M
4
ABUS icon
Arbutus Biopharma
ABUS
$884K
5
SVRA icon
Savara
SVRA
$813K

Sector Composition

1 Healthcare 91.5%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SLGL icon
76
Sol-Gel Technologies
SLGL
$63.5M
$319K 0.12%
35,000
– –
ALDX icon
77
Aldeyra Therapeutics
ALDX
$351M
$300K 0.11%
50,000
– –
KRTX
78
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$200K 0.08%
+10,000
New +$200K
LCTX icon
79
Lineage Cell Therapeutics
LCTX
$267M
$105K 0.04%
95,000
– –
NGM
80
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$92K 0.03%
+6,265
New +$92K
RNTX
81
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
$72K 0.03%
99,502
– –
ORMP icon
82
Oramed Pharmaceuticals
ORMP
$90.2M
$57K 0.02%
16,000
-10,000
-38% -$35.6K
BLCM
83
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$51K 0.02%
30,000
– –
ARCT icon
84
Arcturus Therapeutics
ARCT
$462M
$23K 0.01%
2,400
-44,855
-95% -$430K
ABUS icon
85
Arbutus Biopharma
ABUS
$711M
– –
-246,900
Closed -$884K
NERV icon
86
Minerva Neurosciences
NERV
$16.5M
– –
-36,084
Closed -$284K
SVRA icon
87
Savara
SVRA
$567M
– –
-110,275
Closed -$813K
VBIV
88
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
– –
-850,000
Closed -$1.59M
ADXS
89
DELISTED
Advaxis, Inc.
ADXS
– –
-202,222
Closed -$1.2M
IMMU
90
DELISTED
Immunomedics Inc
IMMU
– –
-5,052
Closed -$97K
1 2 3
4